The Street March 12, 2013
Best And Worst FDA Drug Approval Stocks of 2013
By Adam Feuerstein 03/12/13 - 08:00 AM EDT
I'm on the fence with Aveo's FDA panel but ultimately predicted a negative vote (just barely, I can see it going the other way, too.) I'm definitely
negative on Delcath's FDA panel and the ultimate FDA approval decision. Finally, I'm also positive on Ziopharm.